Stay up-to-date with our latest news, blog articles, videos, and event announcements. Learn from business success stories and gain access to valuable e-books and resources.
From Clinic to Commercial Fill-Finish: A Guide for Biologic Manufacturing As biologic programmes transition from development to commercial fill-finish operations, the focus shifts from flexibility and speed to demonstrable understanding, validation, and lifecycle readiness. This phase is critical for ensuring […]
When a small molecule development programme involves a high-potency Active Pharmaceutical Ingredient (HPAPI), selecting the right Contract Development and Manufacturing Organisation (CDMO) becomes a decision with direct consequences for operator safety, product quality and regulatory compliance. Containment capability is not […]
Contents Aseptic Fill-Finish for Commercial Pre-Filled Syringe Programmes Supporting Sterile Injectable Formats Manufacturing Site: Maisons-Alfort, France Regulatory Certification and Global Compliance Supply Reliability for Global Programmes Evaluating a European CDMO for Pre-Filled Syringes Discuss Your Programme with Adragos Pharma Pre-Filled […]
Selecting a Contract Development and Manufacturing Organisation for High-Potency Active Pharmaceutical Ingredient small molecule programmes requires a structured, evidence-based evaluation. The critical criteria are: validated Occupational Exposure Band 5 containment, Good Manufacturing Practice certification that explicitly covers the high-potency suite, […]
Pharmaceutical and biotech companies selecting sterile injectable contract development and manufacturing organisation (CDMO) services in Europe must evaluate partners across seven critical dimensions: programme-fit and technical capability, regulatory standing and Good Manufacturing Practice (GMP) certifications, Chemistry, Manufacturing and Controls (CMC) […]
April 15, 2026 Adragos Pharma Kawagoe K.K. (Headquarters: Kawagoe, Saitama; Representative Director and President: Masanori Kurogome) has signed a basic agreement with Towa Pharmaceutical Co., Ltd. (Headquarters: Kadoma, Osaka; President and CEO: Itsuro Yoshida) to establish a strategic collaboration aimed […]
Get notified on our latest news.
